Joe W Ferguson's most recent trade in Treace Medical Concepts Inc was a trade of 308,641 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 6, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2021 | 308,641 | 248,994 | - | - | Stock Option (Right to Buy) | |
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 06 Oct 2021 | 308,641 | 419,756 | - | 0.1 | 30,864 | Common Stock |
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | 27 Apr 2021 | 85,575 | 0 | - | - | Series A Preferred Stock | ||
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | 27 Apr 2021 | 85,575 | 85,575 | - | - | Common Stock | ||
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | Other type of transaction at price $ 0.00 per share. | 27 Apr 2021 | 1,981 | 85,575 | - | - | Series A Preferred Stock | |
Treace Medical Concepts Inc | Joe W. Ferguson | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 33,438 | 33,438 | - | - | Stock Option (Right to Buy) |